Bakkt, Inc. (BKKT): Results of Operations and Financial Condition
Bakkt, Inc. (BKKT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a2026-0810xbkktxq226earn.htm EX-99.1 a2026-0810xbkktxq226earn Bakkt Reports Second Quarter 2026 Results - GAAP net income of $80.8 million, or $1.96 per basic and $1.94 per diluted share - Six commercial offerings live across Bakkt Markets; Total Transacting Volume (“TT
How this was made
The 30-second read
Why it matters
Traders can update models for near-term earnings quality (non-cash warrant marks) and forward revenue optionality tied to embedded finance availability now and co-branded card and Neobank-as-a-Service targeting Q4 2026.
Market read
The filing provides fresh numbers (revenue, net income, adjusted EBITDA) and a large non-cash warrant fair-value gain, alongside concrete operational milestones and a Q4 2026 product roadmap.
What to watch
TTV inclusion changed after May 1 via acquired infrastructure, so comparisons versus prior periods may be less clean; also Q4 2026 partner and card launches remain subject to regulatory and partner readiness.
Background
Bakkt filed an 8-K with Q2 2026 financial and operational results, including updates on its Markets, Agent embedded finance, and India-related Transchem warrant position.
Ticker impact
Bakkt reported Q2 2026 results and disclosed a $98.5 million non-cash fair value gain on Transchem warrants plus $168.8 million Q2 TTV.
Near-term volatility likely, with traders focusing on the sustainability of operating performance versus non-cash warrant revaluation and the Q4 2026 embedded finance and co-branded card roadmap.
Net income swung to $80.8 million largely due to a $98.5 million non-cash warrant fair value gain, while adjusted EBITDA loss widened slightly. Operational updates (DTR integration, partner integration availability) provide a forward catalyst, but the core earnings quality is mixed.
Market effects
Signals ongoing execution in crypto-adjacent payments and stablecoin infrastructure, but highlights earnings sensitivity to warrant fair-value marks.
India regulatory approval for Transchem supports Bakkt’s India expansion narrative.
Reinforces cross-border payments and token economy infrastructure buildout, with potential read-through to other regulated crypto infrastructure providers.
Counterpoint
The headline profitability is heavily non-cash, so the market may discount the net income and re-focus on adjusted EBITDA trajectory and revenue quality.
Key entities
- issuerBakkt, Inc.
NYSE-listed crypto and payments infrastructure company reporting Q2 2026 results and Transchem warrant fair-value update.
- strategic partnerTranschem Limited
India entity that allotted 47.5 million warrants to Bakkt after regulatory approvals.
- productBakkt Agent Embedded Finance
Partner integration modules (accounts, payments, international transfers) available now, with conversational interface targeted for Q4 2026.
